Analysis of PD-L1 using immunohistochemistry in tissue microarrays (IHC/TMA) and RNAscope, respectively, revealed significantly increased PD-L1 levels in WHO°2 and °3 meningiomas, both for mRNA and protein expression [40]. This evidence concerns the gene CD274 and meningioma.